Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HNRNPRP2 is a processed pseudogene, meaning it is a nonfunctional genomic element derived from a reverse-transcribed mRNA of an ancestral heterogeneous nuclear ribonucleoprotein R (HNRNPR) gene[1][5]. Pseudogenes commonly lack the regulatory sequences required for transcription or have mutations that prevent production of functional protein[5]. As a result, HNRNPRP2 does not produce an active protein and has no known biological function, disease association, or relevance as a drug target. The gene’s sequence overlaps with the hnRNP family, whose functional members are RNA-binding proteins involved in mRNA metabolism, but HNRNPRP2 itself is not functionally active[2][1][3]. Key Notes: - There is nothing to suggest HNRNPRP2 encodes a therapeutic target or is involved in any disease mechanism; it is a disabled, non-protein-coding genomic sequence[1][5]. - Functional hnRNP R or related proteins (like hnRNP A/B, hnRNP K) should not be confused with pseudogenes such as HNRNPRP2, which are relics without transcriptional or translational activity[2][5]. - As per standardized genomics nomenclature, pseudogenes like HNRNPRP2 are not biomedically actionable, and querying them as potential drug targets or biomarkers is incorrect[1][5]. If your interest is in the functional hnRNP R protein, this is a distinct and separate gene (not the pseudogene), which is an RNA-binding protein involved in mRNA metabolism[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein R pseudogene 2 (HNRNPRP2).